How health care is turning into a consumer product
A new tech boom is changing the business of medicine
TECH AND health care have a fraught relationship. On January 3rd Elizabeth Holmes, founder of Theranos, a startup that once epitomised the promise of combining Silicon Valley’s dynamism with a stodgy health-care market, was convicted of lying to investors about the capabilities of her firm’s blood-testing technology. Yet look beyond Theranos, which began to implode back in 2015, and a much healthier story becomes apparent. This week a horde of entrepreneurs and investors gathered virtually at the annual JPMorgan Chase health-care jamboree. Top of mind was artificial intelligence (AI), digital diagnostics and tele-health—and of a new wave of capital flooding into a vast industry.
This article appeared in the Business section of the print edition under the headline “Move fast and heal things”
From the January 15th 2022 edition
Discover stories from this section and more in the list of contents
Explore the edition
Leaving the seat of power
The doctrine of management by walking around matters more than ever
Hollywood’s Trump-baiting Oscars
As Silicon Valley embraces the president, legacy media steers clear
Europe is set to start cutting red tape—lightly
But those hoping for radical deregulation will be sorely disappointed
Elon Musk spells danger for Accenture, McKinsey and their rivals
Why the American government could turn against consultants
Why Xi Jinping is making nice with China’s tech billionaires
Jack Ma’s return may be the most lucrative of all time
It’s not just AI. China’s medicines are surprising the world, too
Its firms are at the forefront of cheaper, faster drug discovery